---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-010000"
form_type: "8-K"
ticker: "KPRX"
cik: "0001372514"
company_name: "KIORA PHARMACEUTICALS INC"
filed_at: "2022-02-01T23:59:59+00:00"
generated_at: "2026-06-27T12:52:09.707474+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Kiora Pharmaceuticals appoints Erin Parsons to board; Stephen From resigns as Executive Chairman

## Summary
- Stephen From voluntarily resigned as Executive Chairman and board member effective Jan 31, 2022; no disagreement cited.
- From receives 18 monthly severance payments of $33,333, a lump sum of $300,000, COBRA subsidies, and accelerated vesting.
- Erin Parsons appointed as independent Class III director; she founded Parsons Medical Communications and has ophthalmic expertise.
- Paul Chaney appointed as non-executive Chairman, previously serving as Lead Independent Director.

## SEC filing metadata
- accession: 0001104659-22-010000
- form_type: 8-K
- ticker: KPRX
- cik: 0001372514
- company_name: KIORA PHARMACEUTICALS INC
- filed_at: 2022-02-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1372514/000110465922010000/0001104659-22-010000-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1372514/000110465922010000/tm225039d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-010000
- JSON: https://secwatch.observer/filing/0001104659-22-010000.json
- Plain text: https://secwatch.observer/filing/0001104659-22-010000.txt

## Key facts
- Executive change
  Paul Chaney was appointed as non-executive Chairman at KIORA PHARMACEUTICALS INC.
  - Action: appointed
  - Role: non-executive Chairman
  source text: the Board appointed Paul Chaney as non-executive Chairman of the Board
  evidence_url: https://www.sec.gov/Archives/edgar/data/1372514/000110465922010000/0001104659-22-010000-index.htm
- Executive change
  Erin Parsons was appointed as Director at KIORA PHARMACEUTICALS INC.
  - Action: appointed
  - Role: Director
  source text: On January 31, 2022, the Board of Directors (the “Board”) of Kiora Pharmaceuticals, Inc. (the “Company”) appointed Erin Parsons as a member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1372514/000110465922010000/0001104659-22-010000-index.htm
- Executive change
  Stephen From resigned as Executive Chairman at KIORA PHARMACEUTICALS INC.
  - Action: resigned
  - Role: Executive Chairman
  source text: Effective of January 31, 2022, Stephen From voluntarily resigned as Executive Chairman of the Company and as a member of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1372514/000110465922010000/0001104659-22-010000-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.